TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomérieux Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
327,479
|
311,163
|
328,045 |
Financial expenses |
6
|
565
|
635 |
Earnings before taxes |
5,434
|
4,059
|
8,801 |
EBITDA |
7,022
|
7,542
|
12,535 |
Total assets |
135,790
|
121,281
|
129,119 |
Current assets |
124,509
|
108,157
|
112,661 |
Current liabilities |
85,229
|
67,771
|
78,498 |
Equity capital |
23,731
|
30,324
|
32,225 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
31
|
27
![]() |
27 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.5%
|
25.0%
![]() |
25.0% |
Turnover per employee |
10,564
|
11,525
|
12,150 |
Profit as a percentage of turnover |
1.7%
|
1.3%
|
2.7% |
Return on assets (ROA) |
4.0%
|
3.8%
|
7.3% |
Current ratio |
146.1%
|
159.6%
|
143.5% |
Return on equity (ROE) |
22.9%
|
13.4%
|
27.3% |
Change turnover |
16,316
|
-16,882
|
56,484 |
Change turnover % |
5%
|
-5%
|
21% |
Chg. No. of employees |
4
|
0
|
1 |
Chg. No. of employees % |
15%
|
0%
|
4% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.